Results 101 to 110 of about 780,603 (289)

Design Progress of Structural Components of the EU DEMO EC Equatorial Launcher

IEEE Transactions on Plasma Science
The EU DEMO Tokamak is foreseen to be equipped with an electron cyclotron (EC) system for plasma heating, magnetohydrodynamic (MHD) control, and thermal instability suppression.
P. Spaeh, A. Bruschi, R. Chavan, A. Clément, F. Crisinel, A. Čufar, F. Fanale, S. Garavaglia, J. Hogge, A. M. Sánchez, M. Noël, N. Rispoli, D. Strauss, C. Wu   +13 more
semanticscholar   +1 more source

Development of the plasma scenario for EU-DEMO: Status and plans

Fusion Engineering and Design, 2022
Siccinio, M., Graves, J., Kembleton, R., Lux, H., Maviglia, F., Morris, A., Morris, J., Zohm, H. ; https://orcid.org/0000-0002-8870-7806   +7 more
openaire   +2 more sources

Long‐Term Outcomes of Patients With Relapsed/Refractory Neuroblastoma Treated on ANBL1221: A Report From the Children's Oncology Group

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Results of COG ANBL1221 changed treatment paradigms for patients with relapsed/refractory neuroblastoma. Chemoimmunotherapy with irinotecan/temozolomide/dinutuximab is now used as both bridge therapy following suboptimal response to induction and as treatment in first relapse.
Elizabeth Sokol, Arlene Naranjo, Lulu Chen, Rajen Mody, Steven G. DuBois, Rochelle Bagatell, Navin Pinto   +6 more
wiley   +1 more source

EU-DEMO design space exploration and design drivers

Fusion Engineering and Design, 2022
Kembleton, R., Morris, J., Siccinio, M., Maviglia, F.   +3 more
openaire   +2 more sources

BMT4me En Español: Multisite Feasibility and Usability Testing of a Spanish‐Language mHealth Adherence Support App for Spanish‐Speaking Caregivers of Children After Hematopoietic Stem Cell Transplantation and Cancer Treatment

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Medication nonadherence during the first 100 days after pediatric hematopoietic stem cell transplantation (HSCT) and during oncology treatment increases risk for complications. BMT4me is a caregiver‐facing mobile health (mHealth) application providing medication reminders, symptom tracking, and note‐taking features to support ...
Micah A. Skeens, Madeline R. Peek, Bianca Franklin, Emre Sezgin, Melissa Beauchemin   +4 more
wiley   +1 more source

Measurable Residual Disease Monitoring During Treatment for Pediatric Acute Myeloid Leukemia in First Relapse

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Survival after relapse in pediatric acute myeloid leukemia (AML) remains poor, highlighting the critical importance of identifying prognostic factors to guide optimal relapse management. Methods We investigated the prognostic impact of multiparameter flow cytometry (MFC) measurable residual disease (MRD) in 188 patients with first ...
Camilla Poulsen, Kristian Juul Sandahl, Lene Karlsson, Jonas Abrahamsson, Nira Arad‐Cohen, Daniel Cheuk, Barbara De Moerloose, Linda Fogelstrand, Jose Maria Fernandez Navarro, Bianca F. Goemans, Kirsi Jahnukainen, Gertjan Kaspers, Zhanna Kovalova, Monica Cheng Munthe‐Kaas, Ulrika Norén‐Nyström, Josefine Palle, Ramune Pasauliene, Cornelis Jan Pronk, Kadri Saks, Anne Tierens, Henrik Hasle, Kristian Løvvik Juul‐Dam   +21 more
wiley   +1 more source

Discretization error estimation for EU‐DEMO plasma‐edge simulations using SOLPS‐ITER with fluid neutrals

Contributions to Plasma Physics
A grid refinement study is performed for mean‐field plasma boundary simulations with fluid neutrals in an EU‐DEMO geometry. In general, grid convergence of the simulations is achieved, with differences between the finest and second‐finest grid of
W. Van Uytven, W. Dekeyser, F. Subba, S. Wiesen, N. Horsten, Nathan Vervloesem, Martine Baelmans   +6 more
semanticscholar   +1 more source

T2* Magnetic Resonance Imaging Uncovers Hemosiderin Burden in Pediatric Hemophilia: A Call for Sensitive Imaging Biomarkers

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Hemophilic arthropathy remains the leading morbidity in hemophilia despite modern prophylaxis, and early joint damage may be missed by routine exams. This study explored T2* MRI as a noninvasive biomarker of hemosiderin deposition in pediatric hemophilia.
Jessica Garcia, Tarique Hussain, Jeanne Dillenbeck, Matthew Hammer, Annette von Drygalski, Guy Young, Ayesha Zia   +6 more
wiley   +1 more source

High Heat Flux Tests in Support of the 3-D Computational Modeling of Melting for the EU-DEMO First Wall Limiters

IEEE Transactions on Plasma Science
The EU-DEMOnstration fusion power plant (DEMO) first wall protection strategy relies on limiter components to face both normal and off-normal plasma transient events.
M. Richiusa, H. Greuner, B. Böswirth, P. Ireland, Z. Vizvary   +4 more
semanticscholar   +1 more source

Survival by Race and Ethnicity in Children and Adolescents/Young Adults With Relapsed/Refractory Hodgkin Lymphoma: A Pooled Analysis of Children's Oncology Group Trials

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Despite 5‐year survival rates of over 90% among children and adolescents/young adults (CAYAs) with classic Hodgkin lymphoma (cHL), 15%–20% relapse after frontline therapy. Prior analysis of frontline Children's Oncology Group (COG) clinical trials demonstrated that, despite similar rates of relapse, non‐Hispanic Black (NHB) and ...
Mallorie B. Heneghan, Lindsay A. Renfro, Yue Wu, Katia M. Crisler, Erin Marcotte, Tanya Trippett, Terzah Horton, Bradford S. Hoppe, Frank G. Keller, Chris Forlenza, Cindy Schwartz, Kara M. Kelly, Peter D. Cole, Sharon M. Castellino, Justine M. Kahn   +14 more
wiley   +1 more source